Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue

Recruiting

Phase 1

VELGRAFTPhase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue

Sponsor:

Ayu, Inc.

Code:

NCT07498218

Conditions

Diabetic Foot Ulcer (DFU)

Granulation of Chronic Diabetic Wounds

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous chitosan-gelatin matrix

Standard of Care of Diabetic Foot Ulcers

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-25. This information was provided to ClinicalTrials.gov by Ayu, Inc. on 2026-04-15.